Skip to main content
SpringerLink
Log in

sRAGE is associated with low waist circumference and Hb levels in NAFLD

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

Advanced glycation end products (AGEs) and the receptor RAGE interaction is involved in nonalcoholic fatty liver disease (NAFLD). Although exogenously administered soluble RAGE (sRAGE) has been shown to block the harmful effects of AGEs in animal models, there is still controversy about the role of sRAGE in humans. We examined here which anthropometric, metabolic and clinical variables were independent correlates of sRAGE levels in NAFLD patients. The study involved 77 biopsy-proven, unmedictaed NAFLD patients (44 male and 33 female) with a mean age of 43.4±13.0 years old. We examined which anthropometric, metabolic and clinical variables, including liver steatosis and fibrosis markers, are independently associated with serum levels of sRAGE. Mean serum levels of sRAGE were 710.7±290.2 pg/mL. Univariate analysis revealed that waist circumference (inversely), hemoglobin (inversely), number of white blood cells (inversely), total-bilirubin (inversely), free fatty acid (inversely), ferritin (inversely), and HbA1c (inversely) were significantly correlated with serum levels of sRAGE. In multiple stepwise regression analysis, waist circumference (p<0.01, inversely) and hemoglobin (p<0.01, inversely) were independently associated with serum levels of sRAGE (R2=0.176). The present study reveals that low serum levels of sRAGE are independently associated with waist circumference and hemoglobin in patients with NAFLD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yamagishi S, Imaizumi T: Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 2005; 11: 2279–2299

    Article  PubMed  CAS  Google Scholar 

  2. Hyogo H, Yamagishi S: Advanced glycation end products (AGEs) and their involvement in liver disease. Curr Pharm Des 2008; 14: 969–972

    Article  PubMed  CAS  Google Scholar 

  3. Kimura Y, Hyogo H, Yamagishi S, et al: Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. J Gastroenterol 2010; 45: 750–757

    Article  PubMed  CAS  Google Scholar 

  4. Iwamoto K, Kanno K, Hyogo H, et al: Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells. J Gastroenterol 2008; 43: 298–230

    Article  PubMed  CAS  Google Scholar 

  5. Yamagishi S, Matsui T: Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker. Front Biosci (Elite Ed) 20101; 2: 1184–1195

  6. Yamagishi S, Adachi H, Nakamura K, et al: Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects. Metabolism 2006; 55: 1227–1231

    Article  PubMed  CAS  Google Scholar 

  7. Yilmaz Y, Ulukaya E, Gul OO, Arabul M et al: Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease. Clin Biochem 2009; 42: 802–807

    Article  PubMed  CAS  Google Scholar 

  8. Nakamura K, Adachi H, Matsui T, et al: Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients. Metabolism 2009; 58: 421–425

    Article  PubMed  CAS  Google Scholar 

  9. Unoki H, Bujo H, Yamagishi S, et al: Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 2006; 76: 236–244

    Article  PubMed  Google Scholar 

  10. Semba RD, Ferrucci L, Sun K, et al: Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women. Age Ageing 2009; 38: 283–289

    Article  PubMed  Google Scholar 

  11. Iwata H, Ukeda H, Maruyama T, et al: Effect of carbonyl compounds on red blood cells deformability. Biochem Biophys Res Commun 2004; 321: 700–706

    Article  PubMed  CAS  Google Scholar 

  12. Wautier JL, Wautier MP, Schmidt AM, et al: Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994; 91: 7742–7746

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Molecular Sciences, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, 734-8553, Japan

    Hideyuki Hyogo, Takashi Nakahara, Yuki Kimura & Kazuaki Chayama

  2. Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, 830-0011, Japan

    Sho-ichi Yamagishi & Sayaka Maeda

Authors
  1. Hideyuki Hyogo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sho-ichi Yamagishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sayaka Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Nakahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuki Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazuaki Chayama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sho-ichi Yamagishi.

About this article

Cite this article

Hyogo, H., Yamagishi, Si., Maeda, S. et al. sRAGE is associated with low waist circumference and Hb levels in NAFLD. cent.eur.j.med 8, 830–834 (2013). https://doi.org/10.2478/s11536-013-0224-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-013-0224-z

Keywords

Search

Navigation